CA2453782A1 - Core formulation comprising troglitazone and a biguanide - Google Patents
Core formulation comprising troglitazone and a biguanide Download PDFInfo
- Publication number
- CA2453782A1 CA2453782A1 CA002453782A CA2453782A CA2453782A1 CA 2453782 A1 CA2453782 A1 CA 2453782A1 CA 002453782 A CA002453782 A CA 002453782A CA 2453782 A CA2453782 A CA 2453782A CA 2453782 A1 CA2453782 A1 CA 2453782A1
- Authority
- CA
- Canada
- Prior art keywords
- acid
- patient
- troglitazone
- glucopyranosyl
- core
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2001/021616 WO2003005993A1 (en) | 2000-05-01 | 2001-07-10 | Core formulation comprising troglitazone and a biguanide |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2453782A1 true CA2453782A1 (en) | 2003-01-23 |
Family
ID=32067644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002453782A Abandoned CA2453782A1 (en) | 2001-07-10 | 2001-07-10 | Core formulation comprising troglitazone and a biguanide |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1429740A4 (de) |
JP (1) | JP2004536842A (de) |
AU (1) | AU2001273290B2 (de) |
CA (1) | CA2453782A1 (de) |
MX (1) | MXPA04000181A (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7785627B2 (en) * | 2002-09-20 | 2010-08-31 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6416774B1 (en) * | 1996-05-09 | 2002-07-09 | The Trustees Of The University Of Pennsyvania | Hollow bone mineral-like calcium phosphate particles |
US6011049A (en) * | 1997-02-19 | 2000-01-04 | Warner-Lambert Company | Combinations for diabetes |
DE69939485D1 (de) * | 1998-11-12 | 2008-10-16 | Smithkline Beecham Plc | Arzneimittel zur gesteuerten freisetzung eines insulin sensibilisators und metformin |
DE19860699A1 (de) * | 1998-12-30 | 2000-07-06 | Hexal Ag | Pharmazeutische Zusammensetzung |
US6358531B1 (en) * | 1999-02-01 | 2002-03-19 | The Curators Of The University Of Missouri | Method for preparing porous shells or gels from glass particles |
MY125516A (en) * | 1999-11-16 | 2006-08-30 | Smithkline Beecham Plc | Novel composition based on thiazolidinedione and metformin and use |
WO2001035940A2 (en) * | 1999-11-16 | 2001-05-25 | Smithkline Beecham P.L.C. | Pharmaceutical composition comprising a thiazolidinedione-metformin hydrochloride |
US6451342B2 (en) * | 2000-05-01 | 2002-09-17 | Aeropharm Technology Incorporated | Core formulation comprised of troglitazone and a biguanide |
-
2001
- 2001-07-10 EP EP01952549A patent/EP1429740A4/de not_active Withdrawn
- 2001-07-10 CA CA002453782A patent/CA2453782A1/en not_active Abandoned
- 2001-07-10 AU AU2001273290A patent/AU2001273290B2/en not_active Ceased
- 2001-07-10 MX MXPA04000181A patent/MXPA04000181A/es unknown
- 2001-07-10 JP JP2003511800A patent/JP2004536842A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2004536842A (ja) | 2004-12-09 |
MXPA04000181A (es) | 2004-11-22 |
EP1429740A1 (de) | 2004-06-23 |
EP1429740A4 (de) | 2005-01-26 |
AU2001273290B2 (en) | 2004-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6524621B2 (en) | Core formulation | |
US6451342B2 (en) | Core formulation comprised of troglitazone and a biguanide | |
US6403121B1 (en) | Core formulation | |
US6780432B1 (en) | Core formulation | |
US6296874B1 (en) | Core formulation comprising troglitazone and abiguanide | |
KR20010080419A (ko) | 인슐린 감작제 및 다른 항당뇨병 약제의 개선된 방출을위한 제약 조성물 | |
US6461639B2 (en) | Core formulation | |
AU2002253768A1 (en) | Gastric acid secretion inhibiting composition | |
US10045973B2 (en) | Compositions and methods for treating nocturnal acid breakthrough and other related disorders | |
AU2001273289B2 (en) | Core formulation comprising pioglitazone hydrochloride and a biguanide | |
KR100732599B1 (ko) | 조절 방출형 인슐린 감작제용 제약 조성물 | |
AU2001273289A1 (en) | Core formulation comprising pioglitazone hydrochloride and a biguanide | |
AU2001273310B2 (en) | A core formulation | |
WO2007007757A1 (ja) | PPARγアゴニストを含有する医薬組成物 | |
EP1278513B1 (de) | Kernformulierung | |
AU2001273310A1 (en) | A core formulation | |
AU2001257456A1 (en) | A core formulation | |
CA2562009A1 (en) | (r,r)-formoterol in combination with other pharmacological agents | |
AU2001273290B2 (en) | Core formulation comprising troglitazone and a biguanide | |
AU2001273290A1 (en) | Core formulation comprising troglitazone and a biguanide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |